Menopause Therapeutics is a biotechnology company developing non-hormonal therapies to treat hot flashes and other vasomotor symptoms associated with menopause. Their lead candidate targets specific neural pathways to provide relief from these disruptive symptoms.
Funding
Funding not disclosed
Founders
Product
Problem
Many women experience disruptive vasomotor symptoms, such as hot flashes, during menopause, which can significantly impact their quality of life. Current treatments often rely on hormone replacement therapy, which may not be suitable or preferred by all women due to potential side effects and contraindications.
Solution
Pulsar Biomedical (formerly Menopause Therapeutics) is developing non-hormonal therapies to alleviate vasomotor symptoms associated with menopause. Their lead candidate targets specific neural pathways involved in the generation of hot flashes, offering a novel approach to managing these symptoms without the risks associated with hormone-based treatments. By focusing on the underlying neurobiology of menopause-related symptoms, Pulsar Biomedical aims to provide women with safe and effective alternatives for improving their well-being during this transitional phase of life.
Target Audience
The primary target audience is women experiencing menopause and seeking non-hormonal treatments for vasomotor symptoms like hot flashes.
Features
- Non-hormonal therapeutic approach
- Targets specific neural pathways involved in vasomotor symptom generation
- Designed to provide relief from hot flashes and other menopause-related symptoms